169 related articles for article (PubMed ID: 30949812)
1. Epigallocatechin gallate (EGCG) and miR-548m reduce HCV entry through repression of CD81 receptor in HCV cell models.
Mekky RY; El-Ekiaby N; El Sobky SA; Elemam NM; Youness RA; El-Sayed M; Hamza MT; Esmat G; Abdelaziz AI
Arch Virol; 2019 Jun; 164(6):1587-1595. PubMed ID: 30949812
[TBL] [Abstract][Full Text] [Related]
2. Mir-194 is a hepatocyte gate keeper hindering HCV entry through targeting CD81 receptor.
Mekky RY; El-Ekiaby NM; Hamza MT; Elemam NM; El-Sayed M; Esmat G; Abdelaziz AI
J Infect; 2015 Jan; 70(1):78-87. PubMed ID: 25218426
[TBL] [Abstract][Full Text] [Related]
3. (-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry.
Calland N; Albecka A; Belouzard S; Wychowski C; Duverlie G; Descamps V; Hober D; Dubuisson J; Rouillé Y; Séron K
Hepatology; 2012 Mar; 55(3):720-9. PubMed ID: 22105803
[TBL] [Abstract][Full Text] [Related]
4. CLEC4M-positive and CD81-negative Huh7 cells are not susceptible to JFH-1 HCVcc infection but mediate transinfection.
Ishibashi M; Morita N; Nomura-Kawaguchi C; Shimizu Y; Wakita T; Esumi M
Arch Virol; 2014 Nov; 159(11):2949-55. PubMed ID: 24965233
[TBL] [Abstract][Full Text] [Related]
5. The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry.
Ciesek S; von Hahn T; Colpitts CC; Schang LM; Friesland M; Steinmann J; Manns MP; Ott M; Wedemeyer H; Meuleman P; Pietschmann T; Steinmann E
Hepatology; 2011 Dec; 54(6):1947-55. PubMed ID: 21837753
[TBL] [Abstract][Full Text] [Related]
6. (-)-Epigallocatechin-3-gallate enhances poly I:C-induced interferon-λ1 production and inhibits hepatitis C virus replication in hepatocytes.
Wang YZ; Li JL; Wang X; Zhang T; Ho WZ
World J Gastroenterol; 2017 Aug; 23(32):5895-5903. PubMed ID: 28932081
[TBL] [Abstract][Full Text] [Related]
7. Mice Expressing Minimally Humanized CD81 and Occludin Genes Support Hepatitis C Virus Uptake In Vivo.
Ding Q; von Schaewen M; Hrebikova G; Heller B; Sandmann L; Plaas M; Ploss A
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928007
[TBL] [Abstract][Full Text] [Related]
8. (-)-Epigallocatechin-3-gallate inhibits the replication cycle of hepatitis C virus.
Chen C; Qiu H; Gong J; Liu Q; Xiao H; Chen XW; Sun BL; Yang RG
Arch Virol; 2012 Jul; 157(7):1301-12. PubMed ID: 22491814
[TBL] [Abstract][Full Text] [Related]
9. Contradicting roles of miR-182 in both NK cells and their host target hepatocytes in HCV.
El Sobky SA; El-Ekiaby NM; Mekky RY; Elemam NM; Mohey Eldin MA; El-Sayed M; Esmat G; Abdelaziz AI
Immunol Lett; 2016 Jan; 169():52-60. PubMed ID: 26518141
[TBL] [Abstract][Full Text] [Related]
10. MiR-122 decreases HCV entry into hepatocytes through binding to the 3' UTR of OCLN mRNA.
Sendi H; Mehrab-Mohseni M; Foureau DM; Ghosh S; Walling TL; Steuerwald N; Zamor PJ; Kaplan KJ; Jacobs C; Ahrens WA; Russo MW; Clemens MG; Schrum LW; Bonkovsky HL
Liver Int; 2015 Apr; 35(4):1315-23. PubMed ID: 25302477
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus utilizes VLDLR as a novel entry pathway.
Ujino S; Nishitsuji H; Hishiki T; Sugiyama K; Takaku H; Shimotohno K
Proc Natl Acad Sci U S A; 2016 Jan; 113(1):188-93. PubMed ID: 26699506
[TBL] [Abstract][Full Text] [Related]
12. Determinants in the Ig Variable Domain of Human HAVCR1 (TIM-1) Are Required To Enhance Hepatitis C Virus Entry.
Kachko A; Costafreda MI; Zubkova I; Jacques J; Takeda K; Wells F; Kaplan G; Major ME
J Virol; 2018 Mar; 92(6):. PubMed ID: 29321304
[TBL] [Abstract][Full Text] [Related]
13. CD81 Receptor Regions outside the Large Extracellular Loop Determine Hepatitis C Virus Entry into Hepatoma Cells.
Banse P; Moeller R; Bruening J; Lasswitz L; Kahl S; Khan AG; Marcotrigiano J; Pietschmann T; Gerold G
Viruses; 2018 Apr; 10(4):. PubMed ID: 29677132
[TBL] [Abstract][Full Text] [Related]
14. Disruption of Claudin-1 Expression by miRNA-182 Alters the Susceptibility to Viral Infectivity in HCV Cell Models.
Riad SE; Elhelw DS; Shawer H; El-Ekiaby N; Salah A; Zekri A; Esmat G; Amleh A; Abdelaziz AI
Front Genet; 2018; 9():93. PubMed ID: 29616082
[TBL] [Abstract][Full Text] [Related]
15. Polyphenols Inhibit Hepatitis C Virus Entry by a New Mechanism of Action.
Calland N; Sahuc ME; Belouzard S; Pène V; Bonnafous P; Mesalam AA; Deloison G; Descamps V; Sahpaz S; Wychowski C; Lambert O; Brodin P; Duverlie G; Meuleman P; Rosenberg AR; Dubuisson J; Rouillé Y; Séron K
J Virol; 2015 Oct; 89(19):10053-63. PubMed ID: 26202241
[TBL] [Abstract][Full Text] [Related]
16. CD81/CD9 tetraspanins aid plasmacytoid dendritic cells in recognition of hepatitis C virus-infected cells and induction of interferon-alpha.
Zhang S; Kodys K; Babcock GJ; Szabo G
Hepatology; 2013 Sep; 58(3):940-9. PubMed ID: 22577054
[TBL] [Abstract][Full Text] [Related]
17. CD81 large extracellular loop-containing fusion proteins with a dominant negative effect on HCV cell spread and replication.
Grigorov B; Molle J; Rubinstein E; Zoulim F; Bartosch B
J Gen Virol; 2017 Jul; 98(7):1646-1657. PubMed ID: 28721844
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus entry and the tetraspanin CD81.
Farquhar MJ; Harris HJ; McKeating JA
Biochem Soc Trans; 2011 Apr; 39(2):532-6. PubMed ID: 21428934
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA 130a Regulates both Hepatitis C Virus and Hepatitis B Virus Replication through a Central Metabolic Pathway.
Duan X; Li S; Holmes JA; Tu Z; Li Y; Cai D; Liu X; Li W; Yang C; Jiao B; Schaefer EA; Fusco DN; Salloum S; Chen L; Lin W; Chung RT
J Virol; 2018 Apr; 92(7):. PubMed ID: 29321333
[TBL] [Abstract][Full Text] [Related]
20. CD81 expression is important for the permissiveness of Huh7 cell clones for heterogeneous hepatitis C virus infection.
Akazawa D; Date T; Morikawa K; Murayama A; Miyamoto M; Kaga M; Barth H; Baumert TF; Dubuisson J; Wakita T
J Virol; 2007 May; 81(10):5036-45. PubMed ID: 17329343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
